Risperidone Augmentation in Patients With Schizophrenia
Status:
Completed
Trial end date:
2007-03-01
Target enrollment:
Participant gender:
Summary
We propose a double-blind, placebo-controlled trial to study the effectiveness and
tolerability of adding risperidone to stable yet only partially remitted patients with
schizophrenia maintained on clozapine.